Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Compound heterozygous Pkd1l1 variants in a family with two fetuses affected by heterotaxy and complex Chd.

Le Fevre A, Baptista J, Ellard S, Overton T, Oliver A, Gradhand E, Scurr I.

Eur J Med Genet. 2019 Apr 23. pii: S1769-7212(18)30904-2. doi: 10.1016/j.ejmg.2019.04.014. [Epub ahead of print]

PMID:
31026592
2.

Paramedian chest wall dermoid cyst.

Maklad M, Gradhand E, West E.

BMJ Case Rep. 2019 Feb 26;12(2). pii: e228831. doi: 10.1136/bcr-2018-228831. No abstract available.

PMID:
30814107
3.

Infantile cortical hyperostosis manifesting as congenital unilateral proptosis.

Vahdani K, Choleva P, McVeigh K, Gradhand E, Ford R.

Can J Ophthalmol. 2018 Dec;53(6):e249-e252. doi: 10.1016/j.jcjo.2018.01.002. Epub 2018 Mar 7. No abstract available.

PMID:
30503007
4.

Computer Aided Classification of Neuroblastoma Histological Images Using Scale Invariant Feature Transform with Feature Encoding.

Gheisari S, Catchpoole DR, Charlton A, Melegh Z, Gradhand E, Kennedy PJ.

Diagnostics (Basel). 2018 Aug 28;8(3). pii: E56. doi: 10.3390/diagnostics8030056.

5.

Osseous Metaplasia in a Juvenile Rectal Polyp.

Haynes HR, Wiskin AE, Basude D, Gradhand E.

J Pediatr Gastroenterol Nutr. 2018 Dec;67(6):e123. doi: 10.1097/MPG.0000000000001537. No abstract available.

PMID:
28141681
6.

Response to correspondence: An immunohistochemical study of potential diagnostic and therapeutic biomarkers of wild-type gastrointestinal stromal tumours.

Wong NA, Wingate J, Gradhand E.

Histopathology. 2015 Nov;67(5):747-9. doi: 10.1111/his.12690. Epub 2015 May 4. No abstract available.

PMID:
25778792
7.

An immunohistochemical study of potential diagnostic and therapeutic biomarkers of wild-type gastrointestinal stromal tumours.

Wong NA, Wingate J, Gradhand E.

Histopathology. 2015 Sep;67(3):378-85. doi: 10.1111/his.12667. Epub 2015 Mar 17.

PMID:
25659413
8.

Inverse expression of cystein-rich 61 (Cyr61/CCN1) and connective tissue growth factor (CTGF/CCN2) in borderline tumors and carcinomas of the ovary.

Bartel F, Balschun K, Gradhand E, Strauss HG, Dittmer J, Hauptmann S.

Int J Gynecol Pathol. 2012 Sep;31(5):405-15. doi: 10.1097/PGP.0b013e31824d1891.

PMID:
22833079
9.

Knowledge of the anatomical polyp location might bias the pathological classification of histologically equivocal colorectal serrated polyps - a consensus study performed by pathology trainees.

Gunia S, Berg T, Gradhand E, Becker S.

Pathol Res Pract. 2011 Feb 15;207(2):116-20. doi: 10.1016/j.prp.2010.11.007. Epub 2011 Jan 3.

PMID:
21208752
10.

An illegitimate microRNA target site within the 3' UTR of MDM4 affects ovarian cancer progression and chemosensitivity.

Wynendaele J, Böhnke A, Leucci E, Nielsen SJ, Lambertz I, Hammer S, Sbrzesny N, Kubitza D, Wolf A, Gradhand E, Balschun K, Braicu I, Sehouli J, Darb-Esfahani S, Denkert C, Thomssen C, Hauptmann S, Lund A, Marine JC, Bartel F.

Cancer Res. 2010 Dec 1;70(23):9641-9. doi: 10.1158/0008-5472.CAN-10-0527. Epub 2010 Nov 16.

11.

Frequent aberrant methylation of the imprinted IGF2/H19 locus and LINE1 hypomethylation in ovarian carcinoma.

Dammann RH, Kirsch S, Schagdarsurengin U, Dansranjavin T, Gradhand E, Schmitt WD, Hauptmann S.

Int J Oncol. 2010 Jan;36(1):171-9.

PMID:
19956846
12.

Altered tumor formation and evolutionary selection of genetic variants in the human MDM4 oncogene.

Atwal GS, Kirchhoff T, Bond EE, Montagna M, Menin C, Bertorelle R, Scaini MC, Bartel F, Böhnke A, Pempe C, Gradhand E, Hauptmann S, Offit K, Levine AJ, Bond GL.

Proc Natl Acad Sci U S A. 2009 Jun 23;106(25):10236-41. doi: 10.1073/pnas.0901298106. Epub 2009 Jun 4. Erratum in: Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12208. Monagna, Marco [corrected to Montagna, Marco].

13.

Both germ line and somatic genetics of the p53 pathway affect ovarian cancer incidence and survival.

Bartel F, Jung J, Böhnke A, Gradhand E, Zeng K, Thomssen C, Hauptmann S.

Clin Cancer Res. 2008 Jan 1;14(1):89-96. doi: 10.1158/1078-0432.CCR-07-1192.

14.

Ezrin promotes ovarian carcinoma cell invasion and its retained expression predicts poor prognosis in ovarian carcinoma.

Köbel M, Gradhand E, Zeng K, Schmitt WD, Kriese K, Lantzsch T, Wolters M, Dittmer J, Strauss HG, Thomssen C, Hauptmann S.

Int J Gynecol Pathol. 2006 Apr;25(2):121-30.

PMID:
16633060

Supplemental Content

Loading ...
Support Center